The ProScope HR is an effective, user-friendly, and affordable tool for diagnosing hair loss.
July 2010 in “PharmacoEconomics & Outcomes News” February 2021 in “European Chemical Bulletin” This study developed and validated a reverse phase liquid chromatography method to accurately and reliably measure Minoxidil and Finasteride in bulk and marketed formulations.
18 citations
,
October 2010 in “Bioorganic & Medicinal Chemistry Letters” This study found that a new hybrid compound designed from finasteride and epristeride was a potent inhibitor of 5α-reductase with a mechanism similar to finasteride.
June 2022 in “Zenodo (CERN European Organization for Nuclear Research)” January 2018 in “Journal of analytical, bioanalytical and separation techniques” October 2012 in “Sax's Dangerous Properties of Industrial Materials”
14 citations
,
April 2002 in “Brain Research Protocols” Quickly get finasteride from tablets using easy methods.
December 2024 in “Open Repository of the University of Porto (University of Porto)”
2 citations
,
January 2012 in “Journal of The Chilean Chemical Society” This study developed and validated a precise RP-HPLC-PDA method for estimating finasteride in bulk and tablet forms, suitable for quality control use.
July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This article provides promotional content about hair transplant clinics and offers no new research findings; it emphasizes calling their specialists for more information.
August 2023 in “Zenodo (CERN European Organization for Nuclear Research)” The clinic offers hair transplant services and you can call for prices.
September 2023 in “Open Repository of the University of Porto (University of Porto)”
February 2013 in “Social Science Research Network” This article examines why a major health care system's patients cannot access Wal-Mart's low price for finasteride, despite broader availability, due to complex industry and policy factors, without reporting new clinical results.
April 2011 in “ChemInform” A new compound may effectively inhibit the enzyme linked to BPH and hair loss.
January 2025 in “Journal of Prescribing Practice” 33 citations
,
August 2024 in “Frontiers in Drug Discovery” In this article, the authors describe how drug repurposing, supported by large-scale data and artificial intelligence, can make drug discovery more cost-effective and expedient compared to traditional methods, despite certain regulatory challenges.
6 citations
,
July 2018 in “Hair transplant forum international” This abstract contains author information and a disclosure regarding the Mohebi Inserter for hair transplantation but provides no new clinical research findings.
November 2013 in “Hair transplant forum international” This article discusses the author's experience with prescribing generic finasteride for hair restoration but reports no new clinical findings.
2 citations
,
September 2001 in “PubMed” Finasteride is advertised directly to consumers for treating male pattern hair loss.
1 citations
,
January 2003 in “Hair transplant forum international” This article discusses the diverse responses to Internet Marketing Sites in hair restoration and reports no new findings.
January 2005 in “Fuzhou daxue xuebao. Ziran kexue ban” This study developed a rapid and efficient in vitro method using high-performance liquid chromatography to screen for steroid 5 alpha-reductase inhibitors, determining inhibition constants for Finasteride and Epristeride.
October 2021 in “Open Repository of the University of Porto (University of Porto)” December 2004 in “Annales d Urologie” This article examines the PCPT study on whether daily finasteride can reduce prostate cancer incidence, describing its methodology and findings but reporting no new clinical results.
3 citations
,
July 2022 in “BMC chemistry” This study introduced and validated new spectrophotometric methods to simultaneously determine finasteride and tadalafil in Entadfi™ capsules with high sensitivity and without interference from excipients.
February 2006 in “Inpharma Weekly” February 2019 in “Urology” This study observed that the out-of-pocket prices for generic medications used to treat benign prostatic hyperplasia can vary by up to 500% among pharmacies in the Pittsburgh area, with chain pharmacies pricing significantly higher than independents.
September 2004 in “Evidencia actualizacion en la práctica ambulatoria” This study found that the combination of finasteride and doxazosina was more effective in reducing the long-term progression of benign prostatic hyperplasia compared to monotherapy.